Sale!

ALG6 Gene Glycosylation Disorder Type 1C Genetic Test

4,400 د.إ

-21%

The ALG6 Gene Glycosylation Disorder Type 1C Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the ALG6 gene. These mutations are responsible for a type of Congenital Disorders of Glycosylation (CDG), specifically Type 1C, a rare genetic condition. CDGs are a group of inherited metabolic disorders that affect the glycosylation process, where sugars are attached to proteins and lipids, impacting multiple systems in the body including the nervous system, immune system, and gastrointestinal system.

This test, priced at 4400 AED, involves analyzing the patient’s DNA to detect any abnormalities in the ALG6 gene that may lead to the disorder. Early detection through this genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, providing essential information for the diagnosis, treatment planning, and family genetic counseling of ALG6-CDG Type 1C.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ALG6 Gene Glycosylation Disorder Type 1C Genetic Test

Welcome to DNA Labs UAE, where we offer the ALG6 Gene Glycosylation Disorder Type 1C Genetic Test. This test is designed to detect mutations in the ALG6 gene that may cause glycosylation disorder type 1C.

Test Details

The ALG6 gene glycosylation disorder type 1C NGS genetic test is a diagnostic test that analyzes the DNA sequence of the ALG6 gene. By identifying mutations in this gene, we can detect the deficiency in the enzyme ALG6, which is responsible for adding sugar molecules to proteins and lipids in the body.

Individuals with glycosylation disorder type 1C may experience a range of symptoms, including developmental delays, intellectual disability, seizures, and abnormal facial features. Early diagnosis and management of the disorder is crucial for effective treatment.

Our NGS genetic test utilizes next-generation sequencing technology to identify mutations in the ALG6 gene. This advanced technology allows for accurate and reliable results, providing valuable information for healthcare professionals and patients.

Test Components and Price

The ALG6 Gene Glycosylation Disorder Type 1C Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks.

Test Type and Doctor

The ALG6 Gene Glycosylation Disorder Type 1C Genetic Test falls under the category of neurological disorders. It is recommended to consult with a neurologist for this test.

Test Department and Pre Test Information

This test is conducted in our Genetics department. Before undergoing the ALG6 Gene Glycosylation Disorder Type 1C Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by ALG6 Gene Glycosylation Disorder Type 1C.

Contact DNA Labs UAE for more information about the ALG6 Gene Glycosylation Disorder Type 1C Genetic Test and other genetic testing services we offer.

Test Name ALG6 Gene Glycosylation disorder type 1C Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ALG6 Gene Glycosylation disorder type 1C NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ALG6 Gene Glycosylation disorder type 1C
Test Details

ALG6 gene glycosylation disorder type 1C NGS genetic test is a diagnostic test that analyzes the DNA sequence of the ALG6 gene to detect mutations that may cause glycosylation disorder type 1C. This disorder is caused by a deficiency in the enzyme ALG6, which is responsible for adding sugar molecules to proteins and lipids in the body. This deficiency results in abnormal glycosylation of these molecules, leading to a range of symptoms such as developmental delays, intellectual disability, seizures, and abnormal facial features. The NGS genetic test uses next-generation sequencing technology to identify mutations in the ALG6 gene, allowing for early diagnosis and management of the disorder.